ETC
MRNA icon

Exchange Traded Concepts’s Moderna MRNA Stock Holding History

Exchange Traded Concepts’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.32M Buy
33,110
+12,640
+62% +$654K 0.01% 659
2026
Q1 		$1.04M Sell
20,470
-18,152
-47% -$847K 0.01% 798
2025
Q4 		$1.14M Sell
38,622
-4,292
-10% -$117K 0.01% 749
2025
Q3 		$1.11M Buy
42,914
+7,545
+21% +$210K 0.01% 742
2025
Q2 		$976K Buy
35,369
+4,676
+15% +$123K 0.01% 686
2025
Q1 		$870K Buy
30,693
+4,556
+17% +$162K 0.01% 606
2024
Q4 		$1.09M Buy
26,137
+8,579
+49% +$410K 0.02% 532
2024
Q3 		$1.17M Buy
17,558
+10,907
+164% +$1M 0.03% 460
2024
Q2 		$790K Sell
6,651
-5,032
-43% -$637K 0.02% 520
2024
Q1 		$1.24M Sell
11,683
-1,697
-13% -$171K 0.03% 393
2023
Q4 		$1.33M Buy
13,380
+659
+5% +$55.4K 0.04% 337
2023
Q3 		$1.31M Sell
12,721
-23,824
-65% -$2.66M 0.04% 310
2023
Q2 		$4.44M Buy
36,545
+21,623
+145% +$2.88M 0.11% 170
2023
Q1 		$2.29M Buy
14,922
+1,492
+11% +$246K 0.06% 188
2022
Q4 		$2.41M Sell
13,430
-2,786
-17% -$456K 0.07% 172
2022
Q3 		$1.92M Buy
16,216
+4,042
+33% +$613K 0.06% 155
2022
Q2 		$1.74M Sell
12,174
-2,915
-19% -$417K 0.05% 184
2022
Q1 		$2.6M Buy
15,089
+3,761
+33% +$633K 0.05% 187
2021
Q4 		$2.88M Buy
11,328
+936
+9% +$274K 0.06% 203
2021
Q3 		$4M Buy
10,392
+2,466
+31% +$909K 0.1% 128
2021
Q2 		$1.86M Sell
7,926
-3,407
-30% -$609K 0.06% 228
2021
Q1 		$1.48M Buy
11,333
+5,362
+90% +$777K 0.06% 229
2020
Q4 		$624K Buy
5,971
+583
+11% +$59K 0.03% 303
2020
Q3 		$381K Buy
5,388
+2,154
+67% +$150K 0.02% 364
2020
Q2 		$208K Buy
3,234
+521
+19% +$28.5K 0.03% 465
2020
Q1 		$81K Buy
+2,713
New +$62.4K 0.04% 275

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Exchange Traded Concepts's MRNA Position: Q2 2026 in Review

Exchange Traded Concepts increased its Moderna (MRNA) stake by 62% in Q2 2026, buying an estimated $654K and bringing the position to 33,110 shares worth $2.32M. The position accounts for 0.01% of the portfolio, ranked #659.

Exchange Traded Concepts first reported a position in MRNA in Q1 2020 and has held it in 26 quarters since. The position peaked at $4.44M in Q2 2023. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Exchange Traded Concepts held 33,110 shares of Moderna worth $2.32M as of Q2 2026.
  • Exchange Traded Concepts bought 12,640 Moderna shares in Q2 2026, an estimated $654K.
  • Moderna made up 0.01% of Exchange Traded Concepts's portfolio in Q2 2026, its #659 holding.
  • Exchange Traded Concepts first reported a position in Moderna in Q1 2020 and has held it in 26 quarters since.
  • Exchange Traded Concepts's Moderna position peaked at $4.44M in Q2 2023.
  • 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Exchange Traded Concepts's 13F filing for Q2 2026, filed 22 Jul 2026.